HEADER IMMUNE SYSTEM 17-JUN-05 2A0Z TITLE THE MOLECULAR STRUCTURE OF TOLL-LIKE RECEPTOR 3 LIGAND BINDING DOMAIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: TOLL-LIKE RECEPTOR 3; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CD283 ANTIGEN; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 6 EXPRESSION_SYSTEM_COMMON: CABBAGE LOOPER; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: HI5; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 10 EXPRESSION_SYSTEM_VECTOR: PDEST-570 KEYWDS LEUCINE RICH REPEAT, SOLENOID, GLYCOSYLATION, TLR3, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR J.K.BELL,I.BOTOS,P.R.HALL,J.ASKINS,J.SHILOACH,D.M.SEGAL,D.R.DAVIES REVDAT 6 29-JUL-20 2A0Z 1 COMPND REMARK SEQADV HETNAM REVDAT 6 2 1 LINK SITE ATOM REVDAT 5 23-MAY-18 2A0Z 1 KEYWDS REVDAT 4 11-OCT-17 2A0Z 1 REMARK REVDAT 3 13-JUL-11 2A0Z 1 VERSN REVDAT 2 24-FEB-09 2A0Z 1 VERSN REVDAT 1 02-AUG-05 2A0Z 0 JRNL AUTH J.K.BELL,I.BOTOS,P.R.HALL,J.ASKINS,J.SHILOACH,D.M.SEGAL, JRNL AUTH 2 D.R.DAVIES JRNL TITL THE MOLECULAR STRUCTURE OF THE TOLL-LIKE RECEPTOR 3 JRNL TITL 2 LIGAND-BINDING DOMAIN JRNL REF PROC.NATL.ACAD.SCI.USA V. 102 10976 2005 JRNL REFN ISSN 0027-8424 JRNL PMID 16043704 JRNL DOI 10.1073/PNAS.0505077102 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 91.1 REMARK 3 NUMBER OF REFLECTIONS : 50030 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.206 REMARK 3 FREE R VALUE : 0.232 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 2618 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.49 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 55.00 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2630 REMARK 3 BIN FREE R VALUE : 0.3120 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 261 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5378 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 400 REMARK 3 SOLVENT ATOMS : 363 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.56300 REMARK 3 B22 (A**2) : -9.38500 REMARK 3 B33 (A**2) : 5.82200 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.130 REMARK 3 BOND ANGLES (DEGREES) : 1.550 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : 40.73 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : BME.PARAM REMARK 3 PARAMETER FILE 6 : DGLUC.PARAM REMARK 3 PARAMETER FILE 7 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 TOPOLOGY FILE 7 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2A0Z COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-JUN-05. REMARK 100 THE DEPOSITION ID IS D_1000033355. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-OCT-04 REMARK 200 TEMPERATURE (KELVIN) : 70 REMARK 200 PH : 4.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.99997 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL MONOCHROMATOR REMARK 200 SI220 REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MAR REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 50677 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49 REMARK 200 COMPLETENESS FOR SHELL (%) : 89.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.16 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 4000, NA ACETATE, AMMONIUM REMARK 280 SULFATE, PH 4.2, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 290K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 61.27150 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 61.27150 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 70.80150 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 80.39750 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 70.80150 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 80.39750 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 61.27150 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 70.80150 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 80.39750 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 61.27150 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 70.80150 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 80.39750 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E, F, G, H, I, J, REMARK 350 AND CHAINS: K REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 22 REMARK 465 SER A 23 REMARK 465 SER A 24 REMARK 465 THR A 25 REMARK 465 LYS A 697 REMARK 465 ASP A 698 REMARK 465 SER A 699 REMARK 465 ALA A 700 REMARK 465 PRO A 701 REMARK 465 PHE A 702 REMARK 465 GLU A 703 REMARK 465 GLU A 704 REMARK 465 ASN A 705 REMARK 465 LEU A 706 REMARK 465 TYR A 707 REMARK 465 PHE A 708 REMARK 465 GLN A 709 REMARK 465 GLY A 710 REMARK 465 ASP A 711 REMARK 465 TYR A 712 REMARK 465 LYS A 713 REMARK 465 ASP A 714 REMARK 465 ASP A 715 REMARK 465 ASP A 716 REMARK 465 ASP A 717 REMARK 465 LYS A 718 REMARK 465 GLY A 719 REMARK 465 SER A 720 REMARK 465 HIS A 721 REMARK 465 HIS A 722 REMARK 465 HIS A 723 REMARK 465 HIS A 724 REMARK 465 HIS A 725 REMARK 465 HIS A 726 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OD2 ASP A 575 OD2 ASP A 575 4555 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 SER A 198 CB SER A 198 OG 0.095 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 74 51.44 -113.91 REMARK 500 ASN A 85 -155.60 -130.36 REMARK 500 ASN A 109 -157.16 -130.38 REMARK 500 ASN A 140 -135.37 54.12 REMARK 500 ASN A 157 -161.36 -121.32 REMARK 500 ASN A 181 -156.36 -118.08 REMARK 500 GLN A 232 96.22 -68.17 REMARK 500 LEU A 233 -66.83 -103.87 REMARK 500 TRP A 273 31.67 -88.56 REMARK 500 LEU A 297 65.93 -119.40 REMARK 500 ASN A 309 46.23 -140.95 REMARK 500 LEU A 321 49.73 -87.16 REMARK 500 ILE A 338 -51.92 68.70 REMARK 500 SER A 339 -62.32 -95.62 REMARK 500 ASP A 364 72.88 49.54 REMARK 500 SER A 392 118.55 -167.43 REMARK 500 LEU A 393 72.00 -115.93 REMARK 500 LEU A 430 58.63 -102.04 REMARK 500 ASN A 441 -161.25 -121.77 REMARK 500 ASN A 441 -160.88 -121.77 REMARK 500 TYR A 465 68.96 60.85 REMARK 500 ASP A 496 34.13 -88.02 REMARK 500 LEU A 585 58.92 -92.85 REMARK 500 ASN A 599 -77.34 -137.19 REMARK 500 ASN A 620 -161.28 -101.11 REMARK 500 ASN A 678 -56.13 -122.77 REMARK 500 REMARK 500 REMARK: NULL REMARK 999 REMARK 999 SEQUENCE REMARK 999 ACCORDING TO AUTHORS, THE SEQUENCE ENLYFQG IS THE TEV REMARK 999 (TOBACCO ETCH VIRUS) PROTEASE CLEAVAGE SITE AND DYKDDDDK REMARK 999 IS THE FLAG AFFINITY TAG DBREF 2A0Z A 22 703 UNP O15455 TLR3_HUMAN 22 703 SEQADV 2A0Z GLU A 704 UNP O15455 SEE REMARK 999 SEQADV 2A0Z ASN A 705 UNP O15455 SEE REMARK 999 SEQADV 2A0Z LEU A 706 UNP O15455 SEE REMARK 999 SEQADV 2A0Z TYR A 707 UNP O15455 SEE REMARK 999 SEQADV 2A0Z PHE A 708 UNP O15455 SEE REMARK 999 SEQADV 2A0Z GLN A 709 UNP O15455 SEE REMARK 999 SEQADV 2A0Z GLY A 710 UNP O15455 SEE REMARK 999 SEQADV 2A0Z ASP A 711 UNP O15455 SEE REMARK 999 SEQADV 2A0Z TYR A 712 UNP O15455 SEE REMARK 999 SEQADV 2A0Z LYS A 713 UNP O15455 SEE REMARK 999 SEQADV 2A0Z ASP A 714 UNP O15455 SEE REMARK 999 SEQADV 2A0Z ASP A 715 UNP O15455 SEE REMARK 999 SEQADV 2A0Z ASP A 716 UNP O15455 SEE REMARK 999 SEQADV 2A0Z ASP A 717 UNP O15455 SEE REMARK 999 SEQADV 2A0Z LYS A 718 UNP O15455 SEE REMARK 999 SEQADV 2A0Z GLY A 719 UNP O15455 EXPRESSION TAG SEQADV 2A0Z SER A 720 UNP O15455 EXPRESSION TAG SEQADV 2A0Z HIS A 721 UNP O15455 EXPRESSION TAG SEQADV 2A0Z HIS A 722 UNP O15455 EXPRESSION TAG SEQADV 2A0Z HIS A 723 UNP O15455 EXPRESSION TAG SEQADV 2A0Z HIS A 724 UNP O15455 EXPRESSION TAG SEQADV 2A0Z HIS A 725 UNP O15455 EXPRESSION TAG SEQADV 2A0Z HIS A 726 UNP O15455 EXPRESSION TAG SEQRES 1 A 705 ALA SER SER THR THR LYS CYS THR VAL SER HIS GLU VAL SEQRES 2 A 705 ALA ASP CYS SER HIS LEU LYS LEU THR GLN VAL PRO ASP SEQRES 3 A 705 ASP LEU PRO THR ASN ILE THR VAL LEU ASN LEU THR HIS SEQRES 4 A 705 ASN GLN LEU ARG ARG LEU PRO ALA ALA ASN PHE THR ARG SEQRES 5 A 705 TYR SER GLN LEU THR SER LEU ASP VAL GLY PHE ASN THR SEQRES 6 A 705 ILE SER LYS LEU GLU PRO GLU LEU CYS GLN LYS LEU PRO SEQRES 7 A 705 MET LEU LYS VAL LEU ASN LEU GLN HIS ASN GLU LEU SER SEQRES 8 A 705 GLN LEU SER ASP LYS THR PHE ALA PHE CYS THR ASN LEU SEQRES 9 A 705 THR GLU LEU HIS LEU MET SER ASN SER ILE GLN LYS ILE SEQRES 10 A 705 LYS ASN ASN PRO PHE VAL LYS GLN LYS ASN LEU ILE THR SEQRES 11 A 705 LEU ASP LEU SER HIS ASN GLY LEU SER SER THR LYS LEU SEQRES 12 A 705 GLY THR GLN VAL GLN LEU GLU ASN LEU GLN GLU LEU LEU SEQRES 13 A 705 LEU SER ASN ASN LYS ILE GLN ALA LEU LYS SER GLU GLU SEQRES 14 A 705 LEU ASP ILE PHE ALA ASN SER SER LEU LYS LYS LEU GLU SEQRES 15 A 705 LEU SER SER ASN GLN ILE LYS GLU PHE SER PRO GLY CYS SEQRES 16 A 705 PHE HIS ALA ILE GLY ARG LEU PHE GLY LEU PHE LEU ASN SEQRES 17 A 705 ASN VAL GLN LEU GLY PRO SER LEU THR GLU LYS LEU CYS SEQRES 18 A 705 LEU GLU LEU ALA ASN THR SER ILE ARG ASN LEU SER LEU SEQRES 19 A 705 SER ASN SER GLN LEU SER THR THR SER ASN THR THR PHE SEQRES 20 A 705 LEU GLY LEU LYS TRP THR ASN LEU THR MET LEU ASP LEU SEQRES 21 A 705 SER TYR ASN ASN LEU ASN VAL VAL GLY ASN ASP SER PHE SEQRES 22 A 705 ALA TRP LEU PRO GLN LEU GLU TYR PHE PHE LEU GLU TYR SEQRES 23 A 705 ASN ASN ILE GLN HIS LEU PHE SER HIS SER LEU HIS GLY SEQRES 24 A 705 LEU PHE ASN VAL ARG TYR LEU ASN LEU LYS ARG SER PHE SEQRES 25 A 705 THR LYS GLN SER ILE SER LEU ALA SER LEU PRO LYS ILE SEQRES 26 A 705 ASP ASP PHE SER PHE GLN TRP LEU LYS CYS LEU GLU HIS SEQRES 27 A 705 LEU ASN MET GLU ASP ASN ASP ILE PRO GLY ILE LYS SER SEQRES 28 A 705 ASN MET PHE THR GLY LEU ILE ASN LEU LYS TYR LEU SER SEQRES 29 A 705 LEU SER ASN SER PHE THR SER LEU ARG THR LEU THR ASN SEQRES 30 A 705 GLU THR PHE VAL SER LEU ALA HIS SER PRO LEU HIS ILE SEQRES 31 A 705 LEU ASN LEU THR LYS ASN LYS ILE SER LYS ILE GLU SER SEQRES 32 A 705 ASP ALA PHE SER TRP LEU GLY HIS LEU GLU VAL LEU ASP SEQRES 33 A 705 LEU GLY LEU ASN GLU ILE GLY GLN GLU LEU THR GLY GLN SEQRES 34 A 705 GLU TRP ARG GLY LEU GLU ASN ILE PHE GLU ILE TYR LEU SEQRES 35 A 705 SER TYR ASN LYS TYR LEU GLN LEU THR ARG ASN SER PHE SEQRES 36 A 705 ALA LEU VAL PRO SER LEU GLN ARG LEU MET LEU ARG ARG SEQRES 37 A 705 VAL ALA LEU LYS ASN VAL ASP SER SER PRO SER PRO PHE SEQRES 38 A 705 GLN PRO LEU ARG ASN LEU THR ILE LEU ASP LEU SER ASN SEQRES 39 A 705 ASN ASN ILE ALA ASN ILE ASN ASP ASP MET LEU GLU GLY SEQRES 40 A 705 LEU GLU LYS LEU GLU ILE LEU ASP LEU GLN HIS ASN ASN SEQRES 41 A 705 LEU ALA ARG LEU TRP LYS HIS ALA ASN PRO GLY GLY PRO SEQRES 42 A 705 ILE TYR PHE LEU LYS GLY LEU SER HIS LEU HIS ILE LEU SEQRES 43 A 705 ASN LEU GLU SER ASN GLY PHE ASP GLU ILE PRO VAL GLU SEQRES 44 A 705 VAL PHE LYS ASP LEU PHE GLU LEU LYS ILE ILE ASP LEU SEQRES 45 A 705 GLY LEU ASN ASN LEU ASN THR LEU PRO ALA SER VAL PHE SEQRES 46 A 705 ASN ASN GLN VAL SER LEU LYS SER LEU ASN LEU GLN LYS SEQRES 47 A 705 ASN LEU ILE THR SER VAL GLU LYS LYS VAL PHE GLY PRO SEQRES 48 A 705 ALA PHE ARG ASN LEU THR GLU LEU ASP MET ARG PHE ASN SEQRES 49 A 705 PRO PHE ASP CYS THR CYS GLU SER ILE ALA TRP PHE VAL SEQRES 50 A 705 ASN TRP ILE ASN GLU THR HIS THR ASN ILE PRO GLU LEU SEQRES 51 A 705 SER SER HIS TYR LEU CYS ASN THR PRO PRO HIS TYR HIS SEQRES 52 A 705 GLY PHE PRO VAL ARG LEU PHE ASP THR SER SER CYS LYS SEQRES 53 A 705 ASP SER ALA PRO PHE GLU GLU ASN LEU TYR PHE GLN GLY SEQRES 54 A 705 ASP TYR LYS ASP ASP ASP ASP LYS GLY SER HIS HIS HIS SEQRES 55 A 705 HIS HIS HIS MODRES 2A0Z ASN A 52 ASN GLYCOSYLATION SITE MODRES 2A0Z ASN A 70 ASN GLYCOSYLATION SITE MODRES 2A0Z ASN A 196 ASN GLYCOSYLATION SITE MODRES 2A0Z ASN A 252 ASN GLYCOSYLATION SITE MODRES 2A0Z ASN A 265 ASN GLYCOSYLATION SITE MODRES 2A0Z ASN A 275 ASN GLYCOSYLATION SITE MODRES 2A0Z ASN A 291 ASN GLYCOSYLATION SITE MODRES 2A0Z ASN A 398 ASN GLYCOSYLATION SITE MODRES 2A0Z ASN A 413 ASN GLYCOSYLATION SITE MODRES 2A0Z ASN A 507 ASN GLYCOSYLATION SITE MODRES 2A0Z ASN A 636 ASN GLYCOSYLATION SITE HET NAG B 1 14 HET NAG B 2 14 HET NAG C 1 14 HET NAG C 2 14 HET NAG D 1 14 HET NAG D 2 14 HET NAG E 1 14 HET NAG E 2 14 HET BMA E 3 11 HET NAG F 1 14 HET NAG F 2 14 HET NAG G 1 14 HET NAG G 2 14 HET NAG H 1 13 HET NAG H 2 14 HET FUC H 3 10 HET NAG I 1 14 HET NAG I 2 14 HET BMA I 3 11 HET MAN I 4 11 HET BMA I 5 11 HET NAG J 1 14 HET NAG J 2 14 HET FUC J 3 10 HET NAG K 1 14 HET NDG K 2 14 HET NAG A1961 14 HET GLC A 753 12 HET GLC A 754 12 HET SO4 A 752 5 HET SO4 A 750 5 HET SO4 A 751 5 HET BME A1270 4 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM NDG 2-ACETAMIDO-2-DEOXY-ALPHA-D-GLUCOPYRANOSE HETNAM GLC ALPHA-D-GLUCOPYRANOSE HETNAM SO4 SULFATE ION HETNAM BME BETA-MERCAPTOETHANOL FORMUL 2 NAG 20(C8 H15 N O6) FORMUL 5 BMA 3(C6 H12 O6) FORMUL 8 FUC 2(C6 H12 O5) FORMUL 9 MAN C6 H12 O6 FORMUL 11 NDG C8 H15 N O6 FORMUL 13 GLC 2(C6 H12 O6) FORMUL 15 SO4 3(O4 S 2-) FORMUL 18 BME C2 H6 O S FORMUL 19 HOH *363(H2 O) HELIX 1 1 PRO A 67 THR A 72 5 6 HELIX 2 2 GLU A 93 LEU A 98 1 6 HELIX 3 3 LYS A 187 ALA A 195 5 9 HELIX 4 4 GLY A 234 LEU A 245 1 12 HELIX 5 5 PHE A 268 THR A 274 5 7 HELIX 6 6 PHE A 401 ALA A 405 5 5 HELIX 7 7 GLY A 449 ARG A 453 5 5 HELIX 8 8 LEU A 542 LYS A 547 5 6 HELIX 9 9 GLU A 626 ARG A 635 1 10 HELIX 10 10 THR A 650 THR A 664 1 15 HELIX 11 11 GLU A 670 TYR A 675 1 6 HELIX 12 12 PRO A 687 PHE A 691 5 5 SHEET 1 A26 THR A 29 SER A 31 0 SHEET 2 A26 VAL A 34 ASP A 36 -1 O ASP A 36 N THR A 29 SHEET 3 A26 VAL A 55 ASN A 57 1 O ASN A 57 N ALA A 35 SHEET 4 A26 SER A 79 ASP A 81 1 O ASP A 81 N LEU A 56 SHEET 5 A26 VAL A 103 ASN A 105 1 O VAL A 103 N LEU A 80 SHEET 6 A26 GLU A 127 HIS A 129 1 O HIS A 129 N LEU A 104 SHEET 7 A26 THR A 151 ASP A 153 1 O ASP A 153 N LEU A 128 SHEET 8 A26 GLU A 175 LEU A 177 1 O LEU A 177 N LEU A 152 SHEET 9 A26 LYS A 201 GLU A 203 1 O GLU A 203 N LEU A 176 SHEET 10 A26 GLY A 225 PHE A 227 1 O PHE A 227 N LEU A 202 SHEET 11 A26 ASN A 252 SER A 254 1 O ASN A 252 N LEU A 226 SHEET 12 A26 MET A 278 ASP A 280 1 O MET A 278 N LEU A 253 SHEET 13 A26 TYR A 302 PHE A 304 1 O PHE A 304 N LEU A 279 SHEET 14 A26 TYR A 326 ASN A 328 1 O TYR A 326 N PHE A 303 SHEET 15 A26 HIS A 359 ASN A 361 1 O HIS A 359 N LEU A 327 SHEET 16 A26 TYR A 383 SER A 385 1 O SER A 385 N LEU A 360 SHEET 17 A26 ILE A 411 ASN A 413 1 O ILE A 411 N LEU A 384 SHEET 18 A26 VAL A 435 ASP A 437 1 O ASP A 437 N LEU A 412 SHEET 19 A26 GLU A 460 TYR A 462 1 O TYR A 462 N LEU A 436 SHEET 20 A26 ARG A 484 MET A 486 1 O ARG A 484 N ILE A 461 SHEET 21 A26 ILE A 510 ASP A 512 1 O ILE A 510 N LEU A 485 SHEET 22 A26 ILE A 534 ASP A 536 1 O ILE A 534 N LEU A 511 SHEET 23 A26 ILE A 566 ASN A 568 1 O ILE A 566 N LEU A 535 SHEET 24 A26 ILE A 590 ASP A 592 1 O ASP A 592 N LEU A 567 SHEET 25 A26 SER A 614 ASN A 616 1 O SER A 614 N ILE A 591 SHEET 26 A26 GLU A 639 ASP A 641 1 O ASP A 641 N LEU A 615 SHEET 1 B 2 SER A 198 LEU A 199 0 SHEET 2 B 2 ARG A 222 LEU A 223 1 O ARG A 222 N LEU A 199 SHEET 1 C 2 THR A 262 THR A 263 0 SHEET 2 C 2 VAL A 288 VAL A 289 1 O VAL A 288 N THR A 263 SHEET 1 D 2 HIS A 312 LEU A 313 0 SHEET 2 D 2 LYS A 345 ILE A 346 1 O LYS A 345 N LEU A 313 SHEET 1 E 2 THR A 395 LEU A 396 0 SHEET 2 E 2 LYS A 421 ILE A 422 1 O LYS A 421 N LEU A 396 SHEET 1 F 2 GLY A 444 GLU A 446 0 SHEET 2 F 2 TYR A 468 GLN A 470 1 O GLN A 470 N GLN A 445 SHEET 1 G 2 PHE A 647 ASP A 648 0 SHEET 2 G 2 CYS A 677 THR A 679 1 O ASN A 678 N PHE A 647 SSBOND 1 CYS A 28 CYS A 37 1555 1555 2.04 SSBOND 2 CYS A 95 CYS A 122 1555 1555 2.03 SSBOND 3 CYS A 649 CYS A 677 1555 1555 2.03 SSBOND 4 CYS A 651 CYS A 696 1555 1555 2.04 LINK ND2 ASN A 52 C1 NAG B 1 1555 1555 1.46 LINK ND2 ASN A 70 C1 NAG C 1 1555 1555 1.45 LINK ND2 ASN A 196 C1 NAG A1961 1555 1555 1.46 LINK ND2 ASN A 252 C1 NAG D 1 1555 1555 1.45 LINK ND2 ASN A 265 C1 NAG E 1 1555 1555 1.45 LINK ND2 ASN A 275 C1 NAG F 1 1555 1555 1.45 LINK ND2 ASN A 291 C1 NAG G 1 1555 1555 1.45 LINK SG CYS A 356 S2 BME A1270 1555 1555 2.04 LINK ND2 ASN A 398 C1 NAG H 1 1555 1555 1.46 LINK ND2 ASN A 413 C1 NAG I 1 1555 1555 1.45 LINK ND2 ASN A 507 C1 NAG J 1 1555 1555 1.46 LINK ND2 ASN A 636 C1 NAG K 1 1555 1555 1.46 LINK O3 SO4 A 752 C3 NAG H 1 1555 1555 1.43 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.39 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.39 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.39 LINK O4 NAG E 1 C1 NAG E 2 1555 1555 1.38 LINK O4 NAG E 2 C1 BMA E 3 1555 1555 1.39 LINK O4 NAG F 1 C1 NAG F 2 1555 1555 1.39 LINK O4 NAG G 1 C1 NAG G 2 1555 1555 1.39 LINK O4 NAG H 1 C1 NAG H 2 1555 1555 1.39 LINK O6 NAG H 1 C1 FUC H 3 1555 1555 1.40 LINK O4 NAG I 1 C1 NAG I 2 1555 1555 1.39 LINK O4 NAG I 2 C1 BMA I 3 1555 1555 1.39 LINK O3 BMA I 3 C1 MAN I 4 1555 1555 1.40 LINK O6 BMA I 3 C1 BMA I 5 1555 1555 1.41 LINK O4 NAG J 1 C1 NAG J 2 1555 1555 1.39 LINK O6 NAG J 1 C1 FUC J 3 1555 1555 1.41 LINK O4 NAG K 1 C1 NDG K 2 1555 1555 1.40 CISPEP 1 SER A 498 PRO A 499 0 -0.22 CISPEP 2 THR A 679 PRO A 680 0 -0.24 CRYST1 141.603 160.795 122.543 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007062 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006219 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008160 0.00000